Belluscura names Bob Fary to top sales role
By HME News Staff
Updated 10:18 AM CST, Mon January 16, 2023
LONDON and PLANO, Texas – Belluscura has named Bob Fary senior vice president of global sales. Fary has more than 30 years of experience in the respiratory industry, including top roles at major oxygen concentrator manufacturers and DME companies, including Inogen. "We are very excited that Bob has joined our team as we enter the next stage of growth at Belluscura,” said CEO Robert Rauker. “His deep knowledge of the portable oxygen concentrator sector and its channels to market will be invaluable as we build on our success to date to bring our latest generation of POCs to market." During the past two decades, Fary and his team were directly responsible for or contributed to the sale of more than 1 million POCs, generating revenues in excess of $1 billion. "I am delighted to have joined Belluscura at this important juncture for the company as it captures the demand in its markets for its best-in-class products,” Fary said. “The planned launch of DISCOV-R will be another exciting step in meeting the needs of patients around the world. I look forward to working alongside the wider executive team to grow the company's sales in the U.S. and beyond." Belluscura expects to launch the first DISCOV-R POCs for pre-market evaluation in the first quarter, with full commercialization anticipated in the second quarter.
Comments